Ledger.Open graph →
SEC Form D · filed January 22, 2014

Galena Biopharma, Inc

Offering
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Portland, OR
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Stephen S. Galliker · Portland, ORDirectorRudolph A. Nisi, M.D · Portland, ORDirectorMark J. Ahn, Ph.D · Portland, ORExec · DirectorRichard L. Chin, M.D · Portland, ORDirectorMark W. Schwartz, Ph.D · Portland, ORExecRyan A. Dunlap · Portland, ORExecWilliam L. Ashton · Portland, ORDirectorSteven A. Kriegsman · Portland, ORDirectorBrian A. Hamilton, M.D., Ph.D · Portland, ORExecSanford J. Hillsberg · Portland, ORDirectorRichard L. Chin, M.D · Portland, ORDirectorMark W. Schwartz, Ph.D · Portland, ORExecRyan A. Dunlap · Portland, ORExecStephen S. Galliker · Thunder Bay, Ontario, CanadaDirectorWilliam L. Ashton · Portland, ORDirectorRudolph A. Nisi, M.D · Portland, ORDirectorSteven A. Kriegsman · Portland, ORDirectorBrian A. Hamilton, M.D., Ph.D · Portland, ORExecMark J. Ahn, Ph.D · Portland, ORExec · DirectorSanford J. Hillsberg · Portland, ORDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗